Showing results (381-390 of 489) with videos related to

Sort By:
Pageof 49
BMC Cancer|September 4, 2016
The effect of neoadjuvant chemotherapy and chemoradiotherapy on exercise capacity and outcome following upper gastrointestinal cancer surgery: an observational cohort studyM A West, L Loughney, G Ambler, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 16, 2014
The effect of neoadjuvant chemotherapy on physical fitness and survival in patients undergoing oesophagogastric cancer surgeryS Jack, M A West, D Raw, et al.
American Journal of Respiratory and Critical Care Medicine|September 23, 2020
Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic ReviewBartolome R Celli, Julie A Anderson, Nicholas J Cowans, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 25, 2025
Phosphodiesterase inhibition restores hypoxia-induced cerebrovascular dysfunction subsequent to improved systemic redox homeostasis: A randomized, double-blind, placebo-controlled crossover studyBenjamin S Stacey, Christopher J Marley, Hayato Tsukamoto, et al.
ERJ Open Research|March 1, 2019
Impact of pre-enrolment medication use on clinical outcomes in SUMMITJørgen Vestbo, Mark Dransfield, Julie A Anderson, et al.
European Heart Journal|August 14, 2018
Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trialJames Brian Byrd, David E Newby, Julie A Anderson, et al.
Respiratory Medicine|November 18, 2005
Proposal for a multidimensional staging system for chronic obstructive pulmonary diseaseBartolome R Celli, Peter M A Calverley, Stephen I Rennard, et al.
Respiratory Medicine|September 27, 2017
Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trialCourtney Crim, Peter M A Calverley, Julie A Anderson, et al.
American Journal of Respiratory and Critical Care Medicine|July 25, 2017
Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular RiskPeter M A Calverley, Julie A Anderson, Robert D Brook, et al.
Heart (British Cardiac Society)|April 19, 2017
Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular riskRobert D Brook, Julie A Anderson, Peter Ma Calverley, et al.
Pageof 49